PremiumRatingsEdwards Lifesciences: Strong Q4 Performance Overshadowed by Unchanged 2025 Outlook and Capacity Constraints Edwards Lifesciences’ Earnings Call Highlights Strong Growth Early notable gainers among liquid option names on February 12th PremiumThe FlyClosing Bell Movers: Upstart jumps 24%, Lyft slip 9% on earnings Edwards Lifesciences reports Q4 EPS 59c, consensus 55c Edwards Lifesciences sees Q EPS , consensus PremiumPre-EarningsEdwards Lifesciences Corp. (EW) Q4 Earnings Cheat Sheet Edwards Lifesciences upgraded to Buy from Hold at Stifel Edwards Lifesciences upgraded to Buy from Hold at Stifel